Wednesday, June 27, 2012

Medical Marijuana Inc. (OTCBB: MJNA) Shareholder Update - Dixie Elixirs Licensing Expansion

Medical Marijuana Inc. (OTCBB: MJNA) Shareholder Update - Dixie Elixirs Licensing ExpansionOrlando, FL 6/27/12 (StreetBeat) -- Medical Marijuana Inc., (OTCBB:MJNA) a leading hemp industry innovator, is pleased to update its shareholders on the status of its portfolio company, Red Dice Holdings and the Dixie family of products.

Recently, the Company acquired the licensing rights to the Dixie Elixirs brand through its portfolio company Red Dice Holdings, a company designed to license and market Dixie's family of products. Medical Marijuana Inc., owns 60% of Red Dice Holdings.

About Dixie
Dixie Elixirs (www.dixieelixirs.com) is a Denver-based firm which specializes in the production and distribution of food, beverages and other products infused with medicinal cannabis. Dixie Elixirs has been highly successful in providing health and wellness products to the Colorado marketplace for the past 3 years. Recently, Dixie launched "Dixie X", which is a new line of non-THC Hemp-based Cannabidiol (CBD) infused products.

The Dixie Elixirs and Edibles family of products consist of eight distinct and carefully formulated product lines of well over fifty five unique medicinal hemp infused products. This product portfolio includes medicated beverages and tonics, hemp capsules, medicated lozenges and edibles, as well as a full line of topicals and salves as part of the Dixie botanicals line of products which was recently featured on National Geographic's series American Weed.

As one of the worlds most recognized medicinal hemp brands, the Dixie products are available throughout Colorado at over 450 licensed locations, where medical cannabis products are sold. Dixie focuses on the development of innovative and socially acceptable products and continues to develop or acquire new products to expand their overall portfolio.

Expansion Plans
Within 60 days, Red Dice Holdings will launch on-line sales of the CBD based Dixie X and CanChewproducts in the US through licensed distribution companies. Selected international distribution will follow later this year. Hemp-based CBD products are legal in the United States and studies have shown them to be effective in treating a variety of medical conditions including pain management, anxiety, nausea and convulsions. The CBD health and wellness industry is estimated to be a $5 billion market.

For more information regarding CBD-infused products, see the following article:
MMJ CBD Infused Products Article

Within 90 days, Red Dice Holdings will enter into exclusive agreements to license the Dixie Elixirs brand, formulations, proprietary extraction processes, delivery methods, equipment and other intellectual property to carefully selected distribution partners in California, Arizona and Washington D.C. The agreements will include all of the Dixie products including Dixie X andCanChew gum.

According to the published See Change Strategy report, the medical cannabis industry is estimated to be a $1.7 billion market in 2012. Colorado, California and Arizona are estimated to account for 93% or approximately $1.6 billion. Red Dice Holdings will expand the Dixie brand throughout the remaining states and countries where medical cannabis is legal by continuing to develop exclusive licensing agreements.

To support the expansion initiatives, MJNA will launch a major marketing and public awareness campaign within the next 60 days to promote the Dixie and CanChew portfolio of products.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

No comments:

Post a Comment